tradingkey.logo

tradingkey.logo
怜玢


Intuitive Surgical Inc

ISRG
りォッチリストに远加
376.100USD
-21.620-5.44%
取匕時間 08/20, 15:30ET
133.10B時䟡総額
44.97盎近12ヶ月PER

詳现情報 Intuitive Surgical Inc 䌁業名

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical Inc プロフィヌル


䌁業コヌドISRG
䌚瀟名Intuitive Surgical Inc
䞊堎日Jun 13, 2000
最高経営責任者「CEO」Rosa (David J)
埓業員数15638
蚌刞皮類Ordinary Share
決算期末Jun 13
本瀟所圚地1020 Kifer Road
郜垂SUNNYVALE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94086
電話番号14085232100
りェブサむトhttps://www.intuitive.com/en-us/about-us/company
䌁業コヌドISRG
䞊堎日Jun 13, 2000
最高経営責任者「CEO」Rosa (David J)

Intuitive Surgical Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
27.20K
+3.83%
Johnson (Amal M)
Johnson (Amal M)
Independent Director
Independent Director
13.54K
+3.92%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1.56%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
246.80K
+0.39%

よくある質問

Intuitive Surgical Incの䞊䜍5名の株䞻は誰ですか


Intuitive Surgical Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Gary S. Guthart, Ph.D.

Intuitive Surgical IncISRGの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Intuitive Surgical Incの株匏を保有しおいる機関は3941瀟あり、保有株匏の総垂堎䟡倀は玄316.11Mで、党䜓の89.25%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-2709007.00増加しおいたす。

Intuitive Surgical Incの最倧の収益源は䜕ですか


2026Q1においお、Instruments and accessories郚門がIntuitive Surgical Incにずっお最倧の収益を生み出しおおり、その金額は6.02Bで、党収益の59.80%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。